論文種別 | 原著(症例報告除く) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small cell lung cancer. |
掲載誌名 | 正式名:Annals of oncology 略 称:Ann Oncol ISSNコード:09237534/15698041 |
掲載区分 | 国外 |
巻・号・頁 | 30(12),pp.1978-1984 |
著者・共著者 | Yoshioka H, Shimokawa M, Seto T, Morita S, Yatabe Y, Okamoto I, Tsurutani J,
Satouchi M, Hirashima T, Atagi S, Shibata K, Saito H, Toyooka S, Yamamoto N, Nakagawa K, Mitsudomi T. |
発行年月 | 2019/12 |
DOI | 10.1093/annonc/mdz399. |
PMID | 31553438 |